RetractedArticleFrontiers in oncology2023

Retraction: Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin.

Frontiers Editorial OfficePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.